(PharmaNewsWire.Com, October 30, 2017 ) According to the report Asia Pacific Proteomics Market, published by Market Data Forecast, the market has been estimated at USD 2.51 billion in 2016 and is projected to reach USD 4.83 billion by 2021, at a CAGR of 14% during the forecast period from 2016 to 2021.
The term proteome refers to the whole complement of proteins, including the modifications made to a specific set of proteins, produced by an animal or a cell framework. Proteomics refers to the complete comprehensive study of proteomes. Proteomics is used to find proteins which causes cancer and other biological illnesses. Proteomics involves a complete analysis of proteins in complex biological samples. It has evolved as an exciting but challenging discipline. The invention of Mass Spectrometry (MS) has revolutionized the study of proteomics. Continuous improvisation of MS instrumentation has enabled the researchers for better analysis of the proteome. The application of MS is not limited to proteome analysis but also extends to metabolites, lipids, carbohydrates, and metals, among others. One of the remarkable achievements in proteomics was combining liquid chromatography systems with MS.
Proteomics is used to evaluate the rate of protein production, interaction of proteins with one another, involvement of proteins in metabolic pathways, and modification of proteins. In addition, it finds extensive applications in drug discovery, development of personalized medicines, and identification of markers for disease diagnosis, which has led to the stellar growth of the proteomics market in the past few years. With the increase in awareness regarding the benefits of personalized medicines, companies and government organizations have increased their R&D expenditure on the development of proteomics. As per the proteomics market research report, it is estimated that reagents segment will continue to lead the overall market during the forecast period.
The growing incidence of target diseases such as cancer, diabetes, and cardiovascular is expected to be the major factor for the market growth. Increasing requirement for customized medicine, R&D use, technological advancements, and increased financing for proteomics ventures are some of the factors driving the Asia Pacific market. Customized therapies and medicines such as protein sequencing are under research for such diseases. The sudden climatic changes, unhealthy lifestyle, and low awareness about infectious diseases in the low-income countries foster the demand for better diagnosis of fatal diseases. However, decreasing funds in key markets, sequestration cuts in the U.S. and decreased assets for proteomics research, high cost of instruments and hardware, and lack of talented scientists are some of the major factors restraining the Asia Pacific market.
Asia Pacific Proteomics Market: Overview Proteomics is the study of the structure and functions of proteins that can be used in the drug discovery, diagnosis, and treatment of diseases. A proteome is never constant as it differs from one cell to other with time. Large number of organizations invest in the R&D of proteomics to understand the metabolic pathway involved in the progression of disease and the development of novel molecules for its treatment and diagnosis. In addition, organizations such as National Institutes of Health (NIH) and National Science Foundation (NSF) raise funds for various proteomics projects. For instance, in September 2016, NIH announced to fund research on “Proteomics, Immunoassay for TB Activation in HIV Patients”. In 2015, National Cancer Institute offered grants for Clinical Proteomic Tumour Analysis Consortium (CPTAC) program. The governments of European countries also take various initiatives to promote proteomics research. The European Union’s Seventh Framework Programme supports proteomics research by funding a group of proteomics researchers from European institutes for the next four years. In Australia, with assistance from government funding, the R&D expenditure on proteomics is expected to increase by 58% in 2016.
Asia Pacific Proteomics Market: Region-wise Outlook The Asia Pacific region is geographically segmented into China, India, Japan, South Korea, and Australia. Asia Pacific is one of the most lucrative markets for the growth of Proteomics market and is projected to grow the highest during the forecast period. Factors such as growing demographics and emerging economies in countries such as India and China are anticipated to lead the growth of the market in this region. The Asia Pacific is growing at a CAGR of 14%.
About Market Data Forecast: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
